Literature DB >> 33464123

Sex-biased DNA methylation in papillary thyroid cancer.

Rui Han1, Wei Sun1, Jiapeng Huang1, Liang Shao1, Hao Zhang1.   

Abstract

Background: Women have a higher risk of developing papillary thyroid cancer (PTC) than men. DNA methylation is known to differ between men and women. Materials & methods: Using the human methylation 450 BeadChip and RNA-sequence, we profiled the genome-wide DNA methylation patterns of papillary thyroid carcinoma patients and para-carcinoma tissue.
Results: We first identified 398 different expression genes (DEGs) between males and females PTC. Then we analyzed the relationship between differentially methylated positions (DMPs) and DEGs at gene promoter regions and identified 39 genes and explored DMP-DEGs' correlation with immune cell infiltration and tumor purity. We also analyzed the relationship between genomic regions and enhancers.
Conclusion: Our study identified 39 DMP-DEGs providing some new insights into the mechanisms of methylation-mediated gender differences in PTC.

Entities:  

Keywords:  DNA methylation; bioinformatics; differentially methylated positions; papillary thyroid cancer; sex-related differences

Mesh:

Year:  2021        PMID: 33464123     DOI: 10.2217/bmm-2020-0215

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  3 in total

1.  Inflammation Markers Have Important Value in Predicting Relapse in Patients with papillary thyroid carcinoma: A Long-Term Follow-Up Retrospective Study.

Authors:  Yanyi Huang; Yushu Liu; Guoheng Mo; Tao Zhou; Qian Hou; Chaoqun Shi; Qunguang Jiang; Yunxia Lv
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

2.  Male Gender Is Associated with Lymph Node Metastasis but Not with Recurrence in Papillary Thyroid Carcinoma.

Authors:  Jiang Zhu; Rui Huang; Ping Yu; Haoyu Ren; Xinliang Su
Journal:  Int J Endocrinol       Date:  2022-02-28       Impact factor: 3.257

3.  Upregulation of TIMM8A is correlated with prognosis and immune regulation in BC.

Authors:  Yu Zhang; Lin Lin; Yunfei Wu; Pingping Bing; Jun Zhou; Wei Yu
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.